Calidi Biotherapeutics, Inc. 10-Q filing
Filed 2025-11-13 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001493152-25-022372
- Form type
- 10-Q
- CIK
- 0001855485
- Primary document
- https://www.sec.gov/Archives/edgar/data/1855485/000149315225022372/form10-q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Calidi Biotherapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-15.8M | - | - |
| Net Income | $-15.8M | - | - |
| Eps Basic | -6.4 | - | - |
| Eps Diluted | -6.4 | - | - |
| Total Assets | $14.0M | - | - |
| Total Liabilities | $6.8M | - | - |
| Shareholders Equity | $6.9M | - | - |
| Operating Cash Flow | $-16.2M | - | - |